Company Overview of Adamas Pharmaceuticals, Inc.
Key Executives for Adamas Pharmaceuticals, Inc.
|Gregory T. Went Ph.D.||27 Relationships||Co-Founder, Chairman & Chief Executive Officer||53|
|Alfred G. Merriweather||No Relationships||CFO & Principal Accounting Officer||63|
|Richard A. King||15 Relationships||Chief Operating Officer||52|
|Rajiv Patni M.D.||No Relationships||Chief Medical Officer||48|
|Jennifer J. Rhodes||No Relationships||Chief Compliance Officer, Chief Business Officer, General Counsel and Corporate Secretary||47|
Adamas Pharmaceuticals, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Gregory T. Went Ph.D.||27 Relationships||Adamas Pharmaceuticals, Inc.||53|
|William W. Ericson J.D.||153 Relationships||Wildcat Venture Partners||58|
|Richard H. Booth CPA, CLU, ChFC||73 Relationships||Limbach Holdings, Inc.||70|
|Martha J. Demski||35 Relationships||Neothetics, Inc.||64|
|David L. Mahoney||43 Relationships||Symantec Corporation||63|
Adamas Pharmaceuticals, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|Audit Committee||Martha J. Demski||35 Relationships||3 Executives|
|Compensation Committee CPA, CLU, ChFC||Richard H. Booth||73 Relationships||3 Executives|
|Nominating Committee J.D.||William W. Ericson||153 Relationships||2 Executives|
|Corporate Governance Committee J.D.||William W. Ericson||153 Relationships||2 Executives|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation||$7.9M|
|Total Value of Options||$700.0K|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.